112 related articles for article (PubMed ID: 16997515)
1. Pharmacokinetics of omeprazole after intravenous and oral administration to rats with liver cirrhosis induced by dimethylnitrosamine.
Lee DY; Lee I; Lee MG
Int J Pharm; 2007 Feb; 330(1-2):37-44. PubMed ID: 16997515
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic interaction between oltipraz and omeprazole in rats: Competitive inhibition of metabolism of oltipraz by omeprazole via CYP1A1 and 3A2, and of omeprazole by oltipraz via CYP1A1/2, 2D1/2, and 3A1/2.
Lee DY; Kim JW; Lee MG
Eur J Pharm Sci; 2007 Dec; 32(4-5):328-39. PubMed ID: 17935951
[TBL] [Abstract][Full Text] [Related]
3. Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous omeprazole in rats.
Lee DY; Shin HS; Bae SK; Lee MG
Biopharm Drug Dispos; 2006 Jul; 27(5):209-18. PubMed ID: 16586464
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of omeprazole in rats with water deprivation for 72 hours.
Lee DY; Shin HS; Lee I; Lee MG
Biopharm Drug Dispos; 2006 Nov; 27(8):361-70. PubMed ID: 16894645
[TBL] [Abstract][Full Text] [Related]
5. Faster clearance of omeprazole in mutant Nagase analbuminemic rats: possible roles of increased protein expression of hepatic CYP1A2 and lower plasma protein binding.
Lee DY; Jung YS; Kim YC; Kim SY; Lee MG
Biopharm Drug Dispos; 2009 Apr; 30(3):107-16. PubMed ID: 19288444
[TBL] [Abstract][Full Text] [Related]
6. Changes in omeprazole pharmacokinetics in rats with diabetes induced by alloxan or streptozotocin: faster clearance of omeprazole due to induction of hepatic CYP1A2 and 3A1.
Lee DY; Lee MG; Shin HS; Lee I
J Pharm Pharm Sci; 2007; 10(4):420-33. PubMed ID: 18261364
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic changes of oltipraz after intravenous and oral administration to rats with liver cirrhosis induced by dimethylnitrosamine.
Bae SK; Lee SJ; Lee JY; Lee Y; Lee I; Kim SG; Lee MG
Int J Pharm; 2004 May; 275(1-2):227-38. PubMed ID: 15081153
[TBL] [Abstract][Full Text] [Related]
8. Effects of cysteine on the pharmacokinetic parameters of omeprazole in rats with protein-calorie malnutrition: partial restoration of some parameters to control levels by oral cysteine supplementation.
Lee DY; Lee I; Lee MG
JPEN J Parenter Enteral Nutr; 2007; 31(1):37-46. PubMed ID: 17202439
[TBL] [Abstract][Full Text] [Related]
9. Faster clearance of omeprazole in rats with acute renal failure induced by uranyl nitrate: contribution of increased expression of hepatic cytochrome P450 (CYP) 3A1 and intestinal CYP1A and 3A subfamilies.
Lee DY; Jung YS; Shin HS; Lee I; Kim YC; Lee MG
J Pharm Pharmacol; 2008 Jul; 60(7):843-51. PubMed ID: 18549670
[TBL] [Abstract][Full Text] [Related]
10. Effects of bacterial lipopolysaccharide on the pharmacokinetics of metformin in rats.
Choi YH; Lee I; Lee MG
Int J Pharm; 2007 Jun; 337(1-2):194-201. PubMed ID: 17275228
[TBL] [Abstract][Full Text] [Related]
11. Effects of E. Coli lipopolysaccharide on the pharmacokinetics of ipriflavone and its metabolites, M1 and M5, after intravenous and oral administration of ipriflavone to rats: decreased metabolism of ipriflavone due to decreased expression of hepatic CYP1A2 and 2C11.
Chung HJ; Kang HE; Bae EJ; Lee I; Kim SG; Lee MG
J Pharm Sci; 2008 Nov; 97(11):5024-36. PubMed ID: 18314883
[TBL] [Abstract][Full Text] [Related]
12. Faster clearance of mirodenafil in rats with acute renal failure induced by uranyl nitrate: contribution of increased protein expression of hepatic CYP3A1 and intestinal CYP1A1 and 3A1/2.
Choi YH; Lee YS; Kim TK; Lee BY; Lee MG
J Pharm Pharmacol; 2009 Oct; 61(10):1325-32. PubMed ID: 19814864
[TBL] [Abstract][Full Text] [Related]
13. Effects of naringin on the pharmacokinetics of intravenous paclitaxel in rats.
Lim SC; Choi JS
Biopharm Drug Dispos; 2006 Dec; 27(9):443-7. PubMed ID: 17009338
[TBL] [Abstract][Full Text] [Related]
14. Involvement of cytochrome P450 3A4 and P-glycoprotein in first-pass intestinal extraction of omeprazole in rabbits.
Fang HM; Xu JM; Mei Q; Diao L; Chen ML; Jin J; Xu XH
Acta Pharmacol Sin; 2009 Nov; 30(11):1566-72. PubMed ID: 19820718
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and therapeutic effects of oltipraz after consecutive or intermittent oral administration in rats with liver cirrhosis induced by dimethylnitrosamine.
Bae SK; Lee SJ; Kim T; Kim JW; Lee I; Kim SG; Lee MG
J Pharm Sci; 2006 May; 95(5):985-97. PubMed ID: 16544323
[TBL] [Abstract][Full Text] [Related]
16. Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".
Streetman DS; Bleakley JF; Kim JS; Nafziger AN; Leeder JS; Gaedigk A; Gotschall R; Kearns GL; Bertino JS
Clin Pharmacol Ther; 2000 Oct; 68(4):375-83. PubMed ID: 11061577
[TBL] [Abstract][Full Text] [Related]
17. Absolute bioavailability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenous and oral administrations.
Uno T; Niioka T; Hayakari M; Yasui-Furukori N; Sugawara K; Tateishi T
Eur J Clin Pharmacol; 2007 Feb; 63(2):143-9. PubMed ID: 17203292
[TBL] [Abstract][Full Text] [Related]
18. Omeprazole disposition in children following single-dose administration.
Kearns GL; Andersson T; James LP; Gaedigk A; Kraynak RA; Abdel-Rahman SM; Ramabadran K; van den Anker JN
J Clin Pharmacol; 2003 Aug; 43(8):840-8. PubMed ID: 12953341
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic interaction between tamoxifen and ondansetron in rats: non-competitive (hepatic) and competitive (intestinal) inhibition of tamoxifen metabolism by ondansetron via CYP2D subfamily and 3A1/2.
Yang SH; Suh JH; Lee MG
Cancer Chemother Pharmacol; 2010 Feb; 65(3):407-18. PubMed ID: 19504095
[TBL] [Abstract][Full Text] [Related]
20. Salvianolate Reduces Glucose Metabolism Disorders in Dimethylnitrosamine-Induced Cirrhotic Rats.
Tang LR; Tao YY; Liu CH; Wang HN
Chin J Integr Med; 2018 Sep; 24(9):661-669. PubMed ID: 29209957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
